

Despite a reduction in clinic-based testing linked to COVID-19, the introduction of OPSS has been associated with increases in overall testing activity. OPSS uptake was lower among populations with greater potential for unmet need, such as individuals living in more deprived areas. Although OPSS is available to all people living within the commissioned areas, in practice not all individuals with a need for STI testing are aware of it or have the confidence and ability to access it. Differences across all socio-demographic characteristics in the relative change in testing could inadvertently increase existing inequalities in access to care and it is important to offer choice of mode of testing for service users.
Regional Health – Europe
|15th Jan, 2026
|The Lancet
Regional Health – Europe
|14th Dec, 2025
|The Lancet
Regional Health – Europe
|12th Dec, 2025
|The Lancet
Regional Health – Europe
|3rd Dec, 2025
|The Lancet
Regional Health – Europe
|2nd Dec, 2025
|The Lancet
Regional Health – Europe
|8th Nov, 2025
|The Lancet
Regional Health – Europe
|8th Nov, 2025
|The Lancet